Some breast cancer types are more likely than others to recur. Researchers have known this for more than a decade. But they have long wondered why. […]

WASHINGTON — MRI-guided stereotactic body radiotherapy (SBRT) showed sustained benefits over CT-guided SBRT for prostate cancer, in a study. Amar Kishan, MD, of UCLA Health, presented […]

RIO DE JANEIRO — Adding isatuximab, or Isa (Sarclisa, Sanofi-Aventis), to bortezomib, lenalidomide, and dexamethasone (VRd) for the treatment of patients with newly diagnosed, transplant-ineligible multiple […]

WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new […]

The US Food and Drug Administration (FDA) has expanded the approval of nivolumab (Opdivo, Bristol Myers Squibb) for the treatment of certain patients with resectable non–small […]

BARCELONA — Intravenous patient-controlled administration of hydromorphone offers better pain control and higher patient satisfaction compared with conventional oral morphine in managing severe cancer pain, according […]

BARCELONA, Spain — Ethnic Chinese immigrants affected by cancer are a particularly vulnerable group and may face significant barriers to receiving proper diagnosis and treatment, according […]